Insider trades
Richard I. Steinhart, CFO of BioXcel Therapeutics BTAIQ, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $7,461. The latest trade was on 06/15.
Richard I. Steinhart
CFO
- Company
- BioXcel Therapeutics BTAIQ
- First filing
- 23/03/16
- Trades
- 85 trades
- Buys / sales
- 0 / 9
- 12-month net buying
- −$7,461
- Last trade
- 06/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 05/20 | 05/22 | 6,845 sh | $1.09 | $7,461.05 | −20.7% |
BTAIQ | Open-market sale10b5-1 plan | 24/12/16 | 24/12/17 | 577 sh2 trades | $0.36avg. | $207.72 | −2.7% |
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 24/10/03 | 24/10/03 | 7,175 sh | $0.55 | $3,946.25 | −26.1% |
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 24/09/16 | 24/09/17 | 356 sh | $0.69 | $245.64 | −5.4% |
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 24/06/17 | 24/06/18 | 372 sh | $1.26 | $468.72 | −6.4% |
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 24/04/04 | 24/04/08 | 1,069 sh | $2.64 | $2,822.16 | −18.3% |
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 23/05/15 | 23/05/16 | 5,000 sh | $27.17 | $135,850 | −76.9% |
BioXcel TherapeuticsBTAIQ | Open-market sale | 23/03/15 | 23/03/16 | 2,084 sh | $19.50 | $40,638 | −58.1% |